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Pancreatic serous cystadenocarcinoma with invasive 
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Serous cystic neoplasms of the pancreas are almost always benign lesions. However, there are some case reports of malignant 
serous neoplasms of the pancreas. It is very difficult to distinguish malignant and benign tumors. Indeed, only clinicopatho-
logic findings of locoregional invasion and metastasis represent a malignancy. We report a serous cystadenocarcinoma of the 
pancreas that was initially considered to be colon cancer. Post-operatively, the tumor was confirmed to be a malignant serous 
cystic tumor of the pancreas. One year later, the patient remains disease-free.
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INTRODUCTION
Ten to twenty percent of pancreatic cysts are neoplastic, 
while only 1% of pancreatic cysts are malignant [1]. Serous 
and mucinous cystic neoplasms are two types of tumors of 
the exocrine pancreas, and have different biological 
behaviors. 
Mucinous cystic tumors are typically slow-growing, 
but carry a significant potential for malignancy, and thus 
resection is often indicated. In contrast, serous cys-
tadenomas are considered benign tumors with almost no 
malignant potential [2]. In 1989, George et al. [3] published 
the first well-documented serous cystadenocarcinoma 
and proposed it as a new entity.
We report herein a patient with a pancreatic serous cys-
tadenocarcinoma that was initially considered a tumor 
originating from the colon.
CASE REPORT
The patient was a 64-year-old woman with no under-
lying diseases. She had dizziness and hematochezia for 
several months, and sought evaluation at the emergency 
room. An abdomen-pelvic computed tomography (CT) 
was obtained and routine laboratory testing was per-
formed.
The abdomen-pelvic CT showed a 12 × 9 cm mass ad-
jacent to the stomach that invaded the spleen and 
pancreas. In addition, there was a tract formation between Wontae Cho, et al.
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Fig. 1. Computed tomography of the 
pancreatic tumor. The tumor in-
vaded the transverse colon (A) and 
spleen (B). 
the mass and transverse colon (Fig. 1). The origin of the 
mass was not determined, but the transverse colon was 
suspected. Several small nodules in the liver were thought 
to represent metastases, so a liver magnetic resonance 
imaging (MRI) was obtained. On the liver MRI, the small 
nodules in the liver were shown to be benign cysts. There 
were no specific lesions involving the lung and other 
organs.
The hemoglobin was 6.3 g/dL. There were no other ab-
normal laboratory findings. She was given a blood trans-
fusion.
The patient underwent segmental resection of the co-
lon, a distal pancreatectomy, and a splenectomy. There 
was no regional lymph node enlargement or malignant 
ascites.
The gross examination revealed a large hemorrhagic 
mass of the pancreatic tail, with adhesions to the paren-
chyma of the spleen and all layers of the colon. There was 
a fistula tract between the mass and colonic mucosa. 
Multilocular microcystic spaces with diffuse hemorrhage 
were noted (Fig. 2). The mass appeared to replace most of 
the distal pancreas. 
Microscopically, the tumor consisted of numerous mi-
crocysts of various sizes with clear cytoplasm (Fig. 3). The 
histopathologic findings were compatible with serous cys-
tadenocarcinoma of the pancreas, showing invasive 
growth into the spleen and colon.
DISCUSSION
There are two categories of pancreatic cystic neoplams 
(serous and mucinous cystic pancreatic tumors) [1]. 
Mucinous cystic neoplasms of the pancreas have a rela-
tively high potential for malignancy, thus surgical removal 
is the standard treatment [4]. The majority of serous cystic 
neoplasms of the pancreas are benign. The prevalence of 
cancer among serous cystic tumors has been reported to be 
3% since 1989 [2]. However, serous cystic neoplasms, de-
spite their low prevalence and benign histologic features, 
have malignant potential and can fulfill all criteria of can-
cer, including local infiltrative growth and formation of 
distant metastasis [3,4].
The pre-operative differentiation between a benign se-
rous cystadenoma and a malignant serous cystadenocar-
cinoma is difficult. Indeed, the correct diagnosis of serous 
cystadenocarcinoma was not made pre-operatively in any 
of the cases, including the current case [5]. The benign and 
malignant variants appear identical histologically, with 
the only distinguishing feature being gross or microscopic 
evidence of invasiveness. Thus, the utility of cytology or 
histology obtained from a core needle biopsy is limited [6]. 
The pre-operative differentiation of benign from malig-
nant cystic lesions of the pancreas using radiologic exami-
nations is not reliable, except for cases with metastatic 
disease. 
It is difficult to diagnose as a malignant tumor at the 
time of primary surgery in the absence of invasion to ad-
jacent organs or metastases. In some patients, other organ Pancreatic serous cystadenocarcinoma
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Fig. 3. (A) Tumor glands invaded 
into the submucosa layer of the 
colon (H&E, ×40). (B) High-power 
view of microcystic cystadenocar-
cinoma showed cuboidal epithelial 
lining with optically-clear cyto-
plasm (H&E, ×400).
Fig. 2. The cut section exhibited invasive tumor growth into the spleen (A) and fistula tract between the tumor and colonic mucosa (B). The 
cut section of the pancreatic tail showed diffuse microcystic tumor with marked hemorrhagic changes (C).
metastases have been reported to occur several years after 
the primary procedure. In general, the tumors are very 
slow-growing and patients have a long life expectancy 
from the time of diagnosis. Therefore, patients should be 
followed for a long time. 
The opinion that serous cystic neoplasms of the pan-
creas are always benign may have contributed to the rec-
ommendation that resection should be performed only 
when there is evidence of local invasiveness, distant meta-
stasis, or related symptoms [7]. Even when metastatic le-
sions are present, surgical resection of primary tumors 
and metastatic lesions is the most effective treatment [8]. 
Serous cystadenocarcinomas of the pancreas invade ad-
jacent organs, such as the spleen, regional lymph nodes, 
and duodenum. In several cases, the tumor spreads to dis-
tant organs like the liver, lung, and bone marrow [2].
In the current case, the tumor invaded the colon and 
spleen. We could not assume the origin of the mass. 
Post-operatively, a serous cystadenocarcinoma was diag-
nosed without evidence of distant metastasis, but with ex-
tensive tumor invasion into surrounding structures; it was 
unusual that there was fistula formation to the transverse 
colon.
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